Terms: = Breast cancer AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
48 results:
1. Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study.
Kuo ET; Kuo C; Lin CL
PLoS One; 2024; 19(3):e0289519. PubMed ID: 38427628
[TBL] [Abstract] [Full Text] [Related]
2. An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer.
Cizmic A; Romic I; Balla A; Barabino N; Anania G; Baiocchi GL; Bakula B; Balagué C; Berlth F; Bintintan V; Bracale U; Egberts JH; Fuchs HF; Gisbertz SS; Gockel I; Grimminger P; van Hillegersberg R; Inaki N; Immanuel A; Korr D; Lingohr P; Mascagni P; Melling N; Milone M; Mintz Y; Morales-Conde S; Moulla Y; Müller-Stich BP; Nakajima K; Nilsson M; Reeh M; Sileri P; Targarona EM; Ushimaru Y; Kim YW; Markar S; Nickel F; Mitra AT
Surg Endosc; 2024 Feb; 38(2):488-498. PubMed ID: 38148401
[TBL] [Abstract] [Full Text] [Related]
3. Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancer.
Duijm LEM; Strobbe LJA; van Breest Smallenburg V; Op de Coul-Froger CL; Setz-Pels W; Vreuls W; van Beek HC; van Bommel RMG; Voogd AC
Breast; 2023 Dec; 72():103593. PubMed ID: 37890215
[TBL] [Abstract] [Full Text] [Related]
4. Associations between marital quality and the prognosis of breast cancer in young Chinese women: 10.3-year median follow-up.
Yuan L; Cai H; An W; Yuan W; Toloza EM; Song Y; An J
Chin Clin Oncol; 2023 Oct; 12(5):51. PubMed ID: 37872116
[TBL] [Abstract] [Full Text] [Related]
5. Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early breast cancer in China.
Zhong X; Chen P; He P; Wu Y; Suo J; Zhu K; Yan X; Tian T; Yang Q; Luo T
Clin Breast Cancer; 2024 Feb; 24(2):e41-e50. PubMed ID: 37865566
[TBL] [Abstract] [Full Text] [Related]
6. The impact of an online educational game on breast cancer awareness among university female students, Malaysia: a pilot study.
Andrew Tong JW; Hee MQ
BMC Cancer; 2023 Oct; 23(1):947. PubMed ID: 37803291
[TBL] [Abstract] [Full Text] [Related]
7. Long-Term Risk of Being Bedridden in Elderly Patients Who Underwent Oncologic Surgery: A Retrospective Study Using a Japanese Claims Database.
Konishi T; Sasabuchi Y; Matsui H; Tanabe M; Seto Y; Yasunaga H
Ann Surg Oncol; 2023 Aug; 30(8):4604-4612. PubMed ID: 37149549
[TBL] [Abstract] [Full Text] [Related]
8. Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy.
Ma Y; Lv M; Yuan P; Chen X; Liu Z
BMC Cancer; 2023 Mar; 23(1):208. PubMed ID: 36870942
[TBL] [Abstract] [Full Text] [Related]
9. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Tolaney SM; Tarantino P; Graham N; Tayob N; Parè L; Villacampa G; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Barroso-Sousa R; Villagrasa P; DeMeo M; DiLullo M; Zanudo JGT; Weiss J; Wagle N; Partridge AH; Waks AG; Hudis CA; Krop IE; Burstein HJ; Prat A; Winer EP
Lancet Oncol; 2023 Mar; 24(3):273-285. PubMed ID: 36858723
[TBL] [Abstract] [Full Text] [Related]
10. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
[TBL] [Abstract] [Full Text] [Related]
11. HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial.
Guarneri V; Bras-Maristany F; Dieci MV; Griguolo G; Par L; Mar Ín-Aguilera M; Miglietta F; Bottosso M; Giorgi CA; Blasco P; Castillo O; Galv N P; Vivancos A; Villagrasa P; Parker JS; Perou CM; Conte P; Prat A
EBioMedicine; 2022 Nov; 85():104320. PubMed ID: 36374768
[TBL] [Abstract] [Full Text] [Related]
12. Development of an automated liquid biopsy assay for methylated markers in advanced breast cancer.
Fackler MJ; Tulac S; Venkatesan N; Aslam AJ; de Guzman TN; Mercado-Rodriguez C; Cope LM; Downs BM; Vali AH; Ding W; Lehman J; Denbow R; Reynolds J; Buckley ME; Visvanathan K; Umbricht CB; Wolff AC; Stearns V; Bates M; Lai EW; Sukumar S
Cancer Res Commun; 2022 Jun; 2(6):391-401. PubMed ID: 36046124
[TBL] [Abstract] [Full Text] [Related]
13. Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network.
Hequet D; Hamy AS; Girard N; Laas E; Coussy F; Rouzier R; Preau M; Delrieu L; Dumas A; Reyal F
Support Care Cancer; 2022 Jul; 30(7):5991-5999. PubMed ID: 35396963
[TBL] [Abstract] [Full Text] [Related]
14. The association between conventional ultrasound and contrast-enhanced ultrasound appearances and pathological features in small breast cancer.
Chen J; Li CX; Shao SH; Yao MH; Su YJ; Wu R
Clin Hemorheol Microcirc; 2022; 80(4):413-422. PubMed ID: 34842181
[TBL] [Abstract] [Full Text] [Related]
15. Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer.
Xi G; Qiu L; Xu S; Guo W; Fu F; Kang D; Zheng L; He J; Zhang Q; Li L; Wang C; Chen J
BMC Med; 2021 Nov; 19(1):273. PubMed ID: 34789257
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Age, Frailty, and Dementia on Prescribing for Type 2 Diabetes at Hospital Discharge 2012-2016.
Wood SJ; Bell JS; Magliano DJ; Fanning L; Cesari M; Keen CS; Ilomäki J
J Frailty Aging; 2021; 10(4):343-349. PubMed ID: 34549249
[TBL] [Abstract] [Full Text] [Related]
17. Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Guerrero-Zotano Á; Casas AM; Bermejo B; Baena-Cañada JM; Antolin S; Sánchez-Rovira P; Ramos Vázquez M; Garcia-Sáenz JÁ; Antón A; Muñoz M; de Juan A; Jara C; Chacón JI; Arcusa A; Gil-Gil M; Adrover E; Oltra A; Brunet J; González S; Bezares S; Lope V; Martín M; Pollán M
Sci Rep; 2020 May; 10(1):7741. PubMed ID: 32385335
[TBL] [Abstract] [Full Text] [Related]
18. Patients' preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan.
Omori Y; Enatsu S; Cai Z; Ishiguro H
Breast Cancer; 2019 Sep; 26(5):652-662. PubMed ID: 30949915
[TBL] [Abstract] [Full Text] [Related]
19. Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node.
Houvenaeghel G; Cohen M; Raro P; De Troyer J; de Lara CT; Gimbergues P; Gauthier T; Faure-Virelizier C; Vaini-Cowen V; Lantheaume S; Regis C; Darai E; Ceccato V; D'Halluin G; Del Piano F; Villet R; Jouve E; Beedassy B; Theret P; Gabelle P; Zinzindohoue C; Opinel P; Marsollier-Ferrer C; Dhainaut-Speyer C; Colombo PE; Lambaudie E; Tallet A; Boher JM;
BMC Cancer; 2018 Nov; 18(1):1153. PubMed ID: 30463611
[TBL] [Abstract] [Full Text] [Related]
20. A biopsychosocial model of resilience for breast cancer: A preliminary study in mainland China.
Ye ZJ; Peng CH; Zhang HW; Liang MZ; Zhao JJ; Sun Z; Hu GY; Yu YL
Eur J Oncol Nurs; 2018 Oct; 36():95-102. PubMed ID: 30322517
[TBL] [Abstract] [Full Text] [Related]
[Next]
